• Creates a major, global specialty chemicals company
– ~75 percent of estimated pro forma adjusted EBITDA* derived from specialty
chemicals
– More than $10 billion in pro forma revenue
– Boosts pro forma revenue from outside North America to approximately
$3.5 billion
• Significantly enhances focus and expands scale
in three specialty chemical businesses
– Specialty additives and ingredients, paper and water technologies,
and specialty resins
• Creates leadership position in attractive and growing
renewable/sustainable chemistries
– Derives approximately one-third of estimated pro forma EBITDA
from bio-based chemistries
* For the 12 months ended June 30, 2008. Sales & Operating Revenue includes intersegment sales.
EBITDA excludes Ashland Unallocated and Other and Hercules Corporate Items.
Drives stronger, more profitable
and less cyclical earnings
Hercules Acquisition
Strategic Benefits